Skip to content

The development of quantum computers has seen rapid progress in recent years, with global players like Google, IBM and academic labs from Harvard and MIT competing to drive innovation. Amidst this race, multiple different platforms and techniques for achieving scalable, robust quantum computation have emerged. Mikhail Lukin’s Group (Quantum Optics Laboratory), along with MIT scientists, are developing technologies based on ultracold neutral atoms. They will discuss the unique advantages and drawbacks of this platform, highlight one of the last remaining challenges towards scalable neutral-atom quantum computing, and outline how their recent work published in Nature Magazine on the continuous operation of a defect-free array of 3,000 qubits – a world record – addresses this challenge.

Join us for a lunchtime debate, in-person and online, hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. This discussion will explore the surge of interest in increasing access to psychedelics. What are the law and policy choices that would maximize benefits and minimize risk of harm?